Synapse - A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)

A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC) Meeting Abstract

Authors:	Funt, S. A.; Jatwani, K.; Makris, M.; Regazzi, A. M.; Lee, C. H.; Teo, M. Y.; McHugh, D. J.; McCoy, A. S.; Hettich, G.; Wong, P.; Abu-Akeel, M.; Wolchok, J. D.; Merghoub, T.; Al-Ahmadie, H.; Ostrovnaya, I.; Chaim, J.; Durack, J. C.; Iyer, G.; Bajorin, D. F.; Rosenberg, J. E.
Abstract Title:	A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	278s
Language:	English
ACCESSION:	WOS:000487345805382
DOI:	10.1200/JCO.2019.37.15_suppl.4559
PROVIDER:	wos
Notes:	Meeting Abstract: 4559 -- Source: Wos